Why he matters in this case
Prof. Norman is the senior Swedish signatory to the Panel report. The Karolinska Institutet — the institution that elects the Nobel Prize in Physiology or Medicine — carries a specific weight in international medical science. When Karolinska neonatology signs onto a case-by-case finding that there is no medical evidence of deliberate harm, that is not a minority view from a fringe of the specialty. It is the view of a flagship European neonatology department.
Professional background
- Professor of Paediatrics, Karolinska Institutet, Stockholm.
- Long-standing research programme on neonatal outcomes, preterm lung development, and evidence synthesis for neonatal care.
- Contributor to Nordic Neonatal Network outcomes research.
- Panel member on the Shoo Lee International Expert Panel.
What his contribution adds
Like Prof. Darlow’s ANZNN perspective, Prof. Norman’s Nordic perspective is relevant because Sweden runs one of the most data-rich national neonatal registries in the world. A Karolinska neonatologist reading the Letby casebook has immediate access to the baseline outcomes data against which the Countess of Chester cluster should be measured. His reading of the individual cases on the Panel is calibrated to that population baseline.
His participation on the Panel is also useful in answering the common UK press argument that international experts without UK NHS experience cannot properly assess the case. Karolinska neonatology works on a broadly equivalent clinical model to UK tertiary neonatology. The signals that a UK NICU reads from a deteriorating baby are the signals Karolinska neonatology reads too.